Report an error
Spotted something inaccurate in “Oral FGFR3 Inhibitor Shows Growth Benefits in Achondroplasia Children”? Tell us what’s wrong and we’ll check it against the original source.
This form is for factual corrections. We read every report but cannot reply individually.